EntreChem and Biomar SA enter a collaborative agreement
to develop new compounds.
July 31st, 2007 - Oviedo (Spain)
EntreChem has entered a development agreement with Instituto Biomar SA (León, Spain) to exploit EntreChem proprietary technology…
more information
|
EntreChem and Laboratoires Servier sign R&D collaborative agreement.
October 25th, 2006 - Oviedo (Spain)
EntreChem has entered a collaborative agreement with Laboratoires Servier (Paris, France) to exploit EntreChem proprietary technology…
more information
|
EntreChem's cofounder interviewed for Nature Biotechnology
Special Report "Biotech in Spain".
September 19th, 2006 - Nature Biothecnology
Dr. Francisco Morís, co-founder and CEO of EntreChem, is interviewed in the September issue of Nature Biotechnology. The issue runs a Special Report about Biotech companies in Spain…
more information
|
C&EN News cover story mentions EntreChem
glycosylation engineering technology.
September 4th, 2006 - Chemical & Engineerig News
Professor of biology José Salas and coworkers at the University of Oviedo, Spain, use a different tack. They insert into microorganisms plasmids that endow them with the ability to synthesize novel sugars, which are then transferred to natural products by glycosyltransferases…
more information
|
EntreChem enters financing agreement with CDTI.
June 22nd, 2006 - Oviedo (Spain)
EntreChem has signed an agreement with The Centre for the Development of Industrial Technology (CDTI) consisting on a reimbursable loan of 400,000 EUR within the NEOTEC program for promotion of newly created companies focused on technology development…
more information
|
EntreChem secures financing from SRP.
April 1st, 2006 - Oviedo (Spain)
EntreChem has signed an agreement with the “Sociedad Regional de Promoción” of the Principality of Asturias for a special loan (a “participative loan”) to finance start-up activities of EntreChem…
more information
|
EntreChem and Genoma España enter a collaborative agreement.
January 28th, 2006 - Oviedo (Spain)
EntreChem has signed an agreement with Genoma España, and it has been incorporated to Genoma’s Technology Portfolio. The agreement supports the creation of the company as well as represents an infusion…
more information |
